Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based company’s Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration
Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based companys Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration 510(k) clearance. The joint ventures partners would be located in New York City, Columbus, OH, and Knoxville, TN, and would be similar to other joint ventures currently in operation in sites such as Magee Womens Hospital and Englewood Hospital and Medical Center, according to Caprius.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.